Laden...
ScienceDaily: Mind & Brain News |
| Posted: 19 Aug 2021 08:30 AM PDT A new preclinical study suggests that treating people who have aggressive cancers, including melanoma, pancreatic and colorectal cancers, with immune checkpoint inhibitors, quickly followed with mutation-targeted therapy, can help overcome treatment resistance and help people live longer. |
| You are subscribed to email updates from Mind & Brain News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
Laden...
Laden...
© 2024
